| 000 | 01430 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250513081225.0 | ||
| 264 | 0 | _c19930506 | |
| 008 | 199305s 0 0 eng d | ||
| 022 | _a0009-9228 | ||
| 024 | 7 |
_a10.1177/000992289303200409 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGiacoia, G P | |
| 245 | 0 | 0 |
_aHigh-dose urokinase therapy in newborn infants with major vessel thrombosis. _h[electronic resource] |
| 260 |
_bClinical pediatrics _cApr 1993 |
||
| 300 |
_a231-7 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article; Review | ||
| 650 | 0 | 4 | _aAorta, Abdominal |
| 650 | 0 | 4 |
_aAortic Diseases _xdrug therapy |
| 650 | 0 | 4 |
_aEmbolism _xetiology |
| 650 | 0 | 4 | _aFemoral Artery |
| 650 | 0 | 4 |
_aFibrin Fibrinogen Degradation Products _xanalysis |
| 650 | 0 | 4 |
_aHemorrhage _xetiology |
| 650 | 0 | 4 |
_aHeparin _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIliac Artery |
| 650 | 0 | 4 | _aInfant, Newborn |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 |
_aThrombolytic Therapy _xadverse effects |
| 650 | 0 | 4 |
_aThrombosis _xdrug therapy |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aUrokinase-Type Plasminogen Activator _xadministration & dosage |
| 773 | 0 |
_tClinical pediatrics _gvol. 32 _gno. 4 _gp. 231-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1177/000992289303200409 _zAvailable from publisher's website |
| 999 |
_c8461508 _d8461508 |
||